Edition:
United Kingdom

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

7.45USD
8:26pm GMT
Change (% chg)

$-0.25 (-3.25%)
Prev Close
$7.70
Open
$7.75
Day's High
$7.83
Day's Low
$7.36
Volume
35,355
Avg. Vol
49,935
52-wk High
$10.24
52-wk Low
$2.43

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.65 December 12 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.20 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.80 2.00 0.00 0.00
Quarter Ending Mar-18 1 2.00 2.00 2.00 --
Year Ending Dec-17 3 1.66 2.90 0.86 0.12
Year Ending Dec-18 4 5.62 10.00 0.00 0.83
Earnings (per share)
Quarter Ending Dec-17 4 -0.65 -0.28 -0.80 -0.50
Quarter Ending Mar-18 2 -0.81 -0.75 -0.87 --
Year Ending Dec-17 4 -2.93 -2.88 -3.03 -2.79
Year Ending Dec-18 4 -3.11 -2.59 -3.75 -2.63

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.02 0.47 0.45 2,270.00
Quarter Ending Jun-17 0.02 0.25 0.24 1,408.98
Quarter Ending Mar-17 0.02 0.13 0.11 565.00
Quarter Ending Dec-16 0.00 0.13 0.13 0.00
Quarter Ending Sep-16 0.00 0.16 0.16 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.80 0.80 0.80 0.02 0.00
Quarter Ending Mar-18 2.00 2.00 2.00 0.00 --
Year Ending Dec-17 1.66 1.66 1.66 0.33 0.12
Year Ending Dec-18 5.62 5.62 4.50 2.50 0.83

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings